Tax Rate: 18.61%
Is the tax rate high or low?
The tax rate of 18.61% is 20% below its 5-year average of 23.40%, near the low end of its 5-year range (11.51%–39.31%).
12.73% below its 12-month average of 21.33%.
GEHC Tax Rate
Reported quarterly effective tax rate; periods with non-meaningful pretax income are omitted.
GEHC Average Tax Rate Chart
GEHC Current vs Average Tax Rate Chart
GEHC Tax Rate Metrics
TAX RATE
18.61%
TAX RATE AVG TTM
21.33%
TAX RATE AVG 3Y
24.43%
TAX RATE AVG 5Y
22.60%
TAX RATE AVG 10Y
N/A
TAX RATE AVG 15Y
N/A
TAX RATE AVG 20Y
N/A
CURRENT VS TTM AVG
-12.73%
CURRENT VS 3Y AVG
-23.79%
CURRENT VS 5Y AVG
-17.64%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Tax Rate Formula & Definition
Tax rate measures income tax expense as a percentage of income before tax. It helps compare tax efficiency and identify unusual tax effects.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Tax Rate FAQ
- What is the tax rate for GE HealthCare Technologies Inc. (GEHC)?
- The tax rate for GEHC stock is 18.61%.
- Is GE HealthCare Technologies Inc.'s tax rate high or low?
- The tax rate of 18.61% is 20% below its 5-year average of 23.40%, near the low end of its 5-year range (11.51%–39.31%).
- What is the TTM average tax rate for GE HealthCare Technologies Inc. (GEHC)?
- The TTM average tax rate for GEHC stock is 21.33%.
- What is the 3Y average tax rate for GE HealthCare Technologies Inc. (GEHC)?
- The 3Y average tax rate for GEHC stock is 24.43%.
- What is the 5Y average tax rate for GE HealthCare Technologies Inc. (GEHC)?
- The 5Y average tax rate for GEHC stock is 22.60%.
GEHC Tax Rate History
| DATE | TAX RATE |
|---|---|
| 2026-03-31 | 18.61% |
| 2025-12-31 | 26.73% |
| 2025-09-30 | 27.84% |
| 2025-06-30 | 18.43% |
| 2025-03-31 | 15.03% |
| 2024-12-31 | 11.51% |
| 2024-09-30 | 25.53% |
| 2024-06-30 | 24.74% |
| 2024-03-31 | 24.22% |
| 2023-12-31 | 31.69% |
| 2023-09-30 | 39.31% |
| 2023-06-30 | 24.04% |
| 2023-03-31 | 29.85% |
| 2022-12-31 | 21.03% |
| 2022-09-30 | 20.74% |
| 2022-06-30 | 23.94% |
| 2022-03-31 | 24.58% |
| 2021-12-31 | 23.71% |
| 2021-09-30 | 23.63% |
| 2021-06-30 | 18.07% |
| 2021-03-31 | 18.07% |
Related Metrics
About GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. is a global medical technology company that creates, manufactures, and markets a diverse range of medical devices, services, and integrated digital solutions. These offerings are designed to assist in the diagnosis, treatment, and ongoing monitoring of patients. The company boasts an extensive international presence, serving markets across the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, and Hong Kong, among other regions. Its operations are structured across four primary business divisions: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging division specializes in advanced diagnostic imaging technologies, including systems for molecular imaging, Computed Tomography (CT) scans, Magnetic Resonance (MR) imaging, image-guided therapy, and X-ray, alongside specialized women's health products. The Ultrasound segment delivers a comprehensive suite of ultrasound solutions utilized for the screening, diagnosis, treatment, and monitoring of various diseases. These applications span radiology, primary care, women's health, cardiovascular diagnostics, point-of-care, and portable handheld devices, in addition to products supporting surgical visualization and guidance. The Patient Care Solutions segment is dedicated to providing essential medical devices, consumable products, services, and digital platforms. Its portfolio encompasses patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal-infant care products. The Pharmaceutical Diagnostics segment supplies specialized diagnostic agents to the radiology and nuclear medicine industries. These include contrast media pharmaceuticals, administered to patients prior to scans like CT, angiography, X-ray, and MR, to enhance the visibility of internal tissues and structures. It also offers molecular imaging agents, or radiopharmaceuticals – molecular tracers labeled with radioisotopes – injected into patients for advanced diagnostic imaging applications such as Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and specific ultrasound procedures. Established in 2022, GE HealthCare Technologies Inc. maintains its corporate headquarters in Chicago, Illinois.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Peter J. Arduini